These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 28968187)

  • 81. Cell-based assays in GPCR drug discovery. In this issue.
    Biotechnol J; 2008 Apr; 3(4):430. PubMed ID: 18412181
    [No Abstract]   [Full Text] [Related]  

  • 82. The Ancient Link between G-Protein-Coupled Receptors and C-Terminal Phospholipid Kinase Domains.
    van den Hoogen DJ; Meijer HJG; Seidl MF; Govers F
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362235
    [TBL] [Abstract][Full Text] [Related]  

  • 83. G Protein-coupled Receptor Biased Agonism.
    Hodavance SY; Gareri C; Torok RD; Rockman HA
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):193-202. PubMed ID: 26751266
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K
    Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Insights into GPCR pharmacology from the measurement of changes in intracellular cyclic AMP; advantages and pitfalls of differing methodologies.
    Hill SJ; Williams C; May LT
    Br J Pharmacol; 2010 Nov; 161(6):1266-75. PubMed ID: 21049583
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Genetic variation in G-protein-coupled receptors--consequences for G-protein-coupled receptors as drug targets.
    Tang CM; Insel PA
    Expert Opin Ther Targets; 2005 Dec; 9(6):1247-65. PubMed ID: 16300474
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.
    Lee Y; Basith S; Choi S
    J Med Chem; 2018 Jan; 61(1):1-46. PubMed ID: 28657745
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
    Filizola M; Weinstein H
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):577-84. PubMed ID: 16159019
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The Adhesion G Protein-Coupled Receptor GPR97/
    Hsiao CC; Chu TY; Wu CJ; van den Biggelaar M; Pabst C; Hébert J; Kuijpers TW; Scicluna BP; I KY; Chen TC; Liebscher I; Hamann J; Lin HH
    Front Immunol; 2018; 9():2830. PubMed ID: 30559745
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation.
    Peeters MC; van Westen GJ; Li Q; IJzerman AP
    Trends Pharmacol Sci; 2011 Jan; 32(1):35-42. PubMed ID: 21075459
    [TBL] [Abstract][Full Text] [Related]  

  • 91. G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
    Sriram K; Insel PA
    Mol Pharmacol; 2018 Apr; 93(4):251-258. PubMed ID: 29298813
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms.
    Huong Bui DL; Roach A; Li J; Bandekar SJ; Orput E; Raghavan R; Araç D; Sando R
    bioRxiv; 2023 Apr; ():. PubMed ID: 37066404
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Characterization of upregulated adhesion GPCRs in acute myeloid leukemia.
    Yang J; Wu S; Alachkar H
    Transl Res; 2019 Oct; 212():26-35. PubMed ID: 31153896
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Heterodimerization and surface localization of G protein coupled receptors.
    Minneman KP
    Biochem Pharmacol; 2007 Apr; 73(8):1043-50. PubMed ID: 17011524
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A Comprehensive Mutagenesis Screen of the Adhesion GPCR Latrophilin-1/ADGRL1.
    Nazarko O; Kibrom A; Winkler J; Leon K; Stoveken H; Salzman G; Merdas K; Lu Y; Narkhede P; Tall G; Prömel S; Araç D
    iScience; 2018 May; 3():264-278. PubMed ID: 30428326
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Dynamic mass redistribution reveals diverging importance of PDZ-ligands for G protein-coupled receptor pharmacodynamics.
    Camp ND; Lee KS; Cherry A; Wacker-Mhyre JL; Kountz TS; Park JM; Harris DA; Estrada M; Stewart A; Stella N; Wolf-Yadlin A; Hague C
    Pharmacol Res; 2016 Mar; 105():13-21. PubMed ID: 26773201
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Single-molecule diffusion-based estimation of ligand effects on G protein-coupled receptors.
    Yanagawa M; Hiroshima M; Togashi Y; Abe M; Yamashita T; Shichida Y; Murata M; Ueda M; Sako Y
    Sci Signal; 2018 Sep; 11(548):. PubMed ID: 30228224
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Antidepressants, beta-arrestins and GRKs: from regulation of signal desensitization to intracellular multifunctional adaptor functions.
    Golan M; Schreiber G; Avissar S
    Curr Pharm Des; 2009; 15(14):1699-708. PubMed ID: 19442183
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Crystal Structure of the Extracellular Domains of GPR110.
    Wang F; Wang Y; Qiu W; Zhang Q; Yang H; Song G
    J Mol Biol; 2023 Mar; 435(6):167979. PubMed ID: 36716818
    [TBL] [Abstract][Full Text] [Related]  

  • 100. G Protein-Coupled Receptors in cancer: biochemical interactions and drug design.
    Audigier Y; Picault FX; Chaves-Almagro C; Masri B
    Prog Mol Biol Transl Sci; 2013; 115():143-73. PubMed ID: 23415094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.